PELP1 and posterior cortical atrophy: Despite its large molecular weight, peptidomimetics against PELP-1 in primary PCa explants and PCa xenografts have shown promise in disrupting AR translocation to the nucleus, resulting in decreased AR-mediated transcription [28].